Eliminating the "expensive" adjective for clinical trials

Am Heart J. 2014 Apr;167(4):419-20. doi: 10.1016/j.ahj.2013.12.003. Epub 2013 Dec 19.

Authors

Michael S Lauer¹, Denise Bonds²

Affiliations

¹ Division of Cardiovascular Sciences (DCVS) of the National Heart Lung and Blood Institute (NHLBI), Bethesda, MD. Electronic address: lauerm@nhlbi.nih.gov.
² Division of Cardiovascular Sciences (DCVS) of the National Heart Lung and Blood Institute (NHLBI), Bethesda, MD.

PMID: 24655687
DOI: 10.1016/j.ahj.2013.12.003

No abstract available

Publication types

Editorial

MeSH terms

Clinical Trials as Topic / economics*
Clinical Trials as Topic / standards
Cost-Benefit Analysis
Health Care Costs*
Humans
United States